Lv11
78 积分 2023-12-08 加入
The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus
6小时前
已完结
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study
3个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
6个月前
已完结
The m 6 A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus
7个月前
已完结
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
11个月前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
11个月前
已完结
皖公网安备34019202002308
